Safety of Contrast Administration for Endocardial Enhancement During Stress Echocardiography Compared With Noncontrast Stress

American Journal of Cardiology

Volumn 102, Issue 11, 2008, Pages 1444-1450

  Shaikh, Kamran ^a   Chang, Su Min ^a   Peterson, Leif ^a   Rosendahl Garcia, Kathleen ^a   Quinones, Miguel A ^a   Nagueh, Sherif F ^a   Kurrelmeyer, Karla ^a   Zoghbi, William A ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ATROPINE; DIPYRIDAMOLE; DOBUTAMINE; PERFLUTREN;

ACUTE HEART INFARCTION; ADULT; AGED; ANAPHYLAXIS; ARTICLE; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; CARDIOPULMONARY ARREST; CARDIOVASCULAR RISK; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSPNEA; ELECTROCARDIOGRAM; FATIGUE; FEMALE; HEADACHE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; LEG PAIN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NAUSEA; PRIORITY JOURNAL; RADIOCARDIOGRAPHY; RISK ASSESSMENT; STRESS ECHOCARDIOGRAPHY; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; VOMITING;

AGED; CONTRAST MEDIA; CORONARY ARTERY DISEASE; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; ENDOCARDIUM; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 56349146613     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.07.032     Document Type: Article

References (29)

1. FDA. New U.S. Food and Drug Administration prescribing information for Definity approved October 10th, 2007. http://www fda gov/cder/foi/label/2007/021064s007lbl.pdf Accessed October 15, 2007
2. Cohen J.L., Cheirif J., Segar D.S., Gillam L.D., Gottdiener J.S., Hausnerova E., and Bruns D.E. Improved left ventricular endocardial border delineation and opacification with Optison (FS069), a new echocardiographic contrast agent. Results of a phase III multicenter trial. J Am Coll Cardiol 32 (1998) 746-752
3. Hundley W.G., Kizilbash A.M., Afridi I., Franco F., Peshock R.M., and Grayburn P.A. Effect of contrast enhancement on transthoracic echocardiographic assessment of left ventricular regional wall motion. Am J Cardiol 84 (1999) 1365-1369
4. Kitzman D.W., Goldman M.E., Gillam L.D., Cohen J.L., Aurigemma G.P., and Gottdiener J.S. Efficacy and safety of the novel ultrasound contrast agent perflutren (Definity) in patients with suboptimal baseline left ventricular echocardiographic images. Am J Cardiol 86 (2000) 669-674
5. Kitzman D.W., and Wesley D.J. Safety assessment of perflenapent emulsion for echocardiographic contrast enhancement in patients with congestive heart failure or chronic obstructive pulmonary disease. Am Heart J 139 (2000) 1077-1080
6. Kusnetzky L.L., Khalid A., Khumri T.M., Moe T.G., Jones P.G., and Main M.L. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies. J Am Coll Cardiol 51 (2008) 1704-1706
7. Main M.L., Goldman J.H., and Grayburn P.A. Thinking outside the "box"-the ultrasound contrast controversy. J Am Coll Cardiol 50 (2007) 2434-2437
8. Mathias Jr. W., Arruda A.L., Andrade J.L., Filho O.C., and Porter T.R. Endocardial border delineation during dobutamine infusion using contrast echocardiography. Echocardiography 19 (2002) 109-114
9. Nanda N.C., Kitzman D.W., Dittrich H.C., and Hall G. Imagent improves endocardial border delineation, inter-reader agreement, and the accuracy of segmental wall motion assessment. Echocardiography 20 (2003) 151-161
10. Timperley J., Mitchell A.R., Thibault H., Mirza I.H., and Becher H. Safety of contrast dobutamine stress echocardiography: a single center experience. J Am Soc Echocardiogr 18 (2005) 163-167
11. Aggeli C., Giannopoulos G., Roussakis G., Christoforatou E., Marinos G., Toli C., Pitsavos C., and Stefanadis C. Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for detection of ischemia in 5250 studies. Heart (2008) doi:10.1136/hrt.2007.135145
12. Tsutsui J.M., Elhendy A., Xie F., O'Leary E.L., McGrain A.C., and Porter T.R. Safety of dobutamine stress real-time myocardial contrast echocardiography. J Am Coll Cardiol 45 (2005) 1235-1242
13. Mulvagh S.L., DeMaria A.N., Feinstein S.B., Burns P.N., Kaul S., Miller J.G., Monaghan M., Porter T.R., Shaw L.J., and Villanueva F.S. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr 13 (2000) 331-342
14. Waggoner A.D., Ehler D., Adams D., Moos S., Rosenbloom J., Gresser C., Perez J.E., and Douglas P.S. Guidelines for the cardiac sonographer in the performance of contrast echocardiography: recommendations of the American Society of Echocardiography Council on Cardiac Sonography. J Am Soc Echocardiogr 14 (2001) 417-420
15. Armstrong W.F., Pellikka P.A., Ryan T., Crouse L., and Zoghbi W.A. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 11 (1998) 97-104
16. Dolan M.S., Riad K., El-Shafei A., Puri S., Tamirisa K., Bierig M., St V.J., McKinney L., Havens E., Habermehl K., et al. Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. Am Heart J 142 (2001) 908-915
17. Douglas P.S., Khandheria B., Stainback R.F., Weissman N.J., Peterson E.D., Hendel R.C., Stainback R.F., Blaivas M., Des Prez R.D., Gillam L.D., et al. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. J Am Coll Cardiol 51 (2008) 1127-1147
18. Rainbird A.J., Mulvagh S.L., Oh J.K., McCully R.B., Klarich K.W., Shub C., Mahoney D.W., and Pellikka P.A. Contrast dobutamine stress echocardiography: clinical practice assessment in 300 consecutive patients. J Am Soc Echocardiogr 14 (2001) 378-385
19. Plana J.C., Mikati I.A., Dokainish H., Lakkis N., Abukhalil J., Davis R., Hetzell B.C., and Zoghbi W.A. A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease: the OPTIMIZE trial. J Am Coll Cardiol Img 1 (2008) 145-152
20. Cortigiani L., Picano E., Coletta C., Chiarella F., Mathias W., Gandolfo N., De A.M., Mazzoni V., Gensini G.F., and Landi P. Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting. Am Heart J 141 (2001) 621-629
21. Mathias Jr. W., Arruda A., Santos F.C., Arruda A.L., Mattos E., Osorio A., Campos O., Gil M., Andrade J.L., and Carvalho A.C. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4,033 consecutive studies. J Am Soc Echocardiogr 12 (1999) 785-791
22. Secknus M.A., and Marwick T.H. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol 29 (1997) 1234-1240
23. Varga A., Garcia M.A., and Picano E. Safety of stress echocardiography (from the International Stress Echo Complication Registry). Am J Cardiol 98 (2006) 541-543
24. Dijkmans P.A., Visser C.A., and Kamp O. Adverse reactions to ultrasound contrast agents: is the risk worth the benefit?. Eur J Echocardiogr 6 (2005) 363-366
25. Fisher N.G., Christiansen J.P., Klibanov A., Taylor R.P., Kaul S., and Lindner J.R. Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol 40 (2002) 811-819
26. Jakobsen J.A., Oyen R., Thomsen H.S., and Morcos S.K. Safety of ultrasound contrast agents. Eur Radiol 15 (2005) 941-945
27. Chen S., Kroll M.H., Shohet R.V., Frenkel P., Mayer S.A., and Grayburn P.A. Bioeffects of myocardial contrast microbubble destruction by echocardiography. Echocardiography 19 (2002) 495-500
28. Vancraeynest D., Kefer J., Hanet C., Fillee C., Beauloye C., Pasquet A., Gerber B.L., Philippe M., and Vanoverschelde J.L. Release of cardiac bio-markers during high mechanical index contrast-enhanced echocardiography in humans. Eur Heart J 28 (2007) 1236-1241
29. Pacold I., Kleinman B., Gunnar R., and Loeb H.S. Effects of low-dose dobutamine on coronary hemodynamics, myocardial metabolism, and anginal threshold in patients with coronary artery disease. Circulation 68 (1983) 1044-1050